Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 45Terminated 15Recruiting 13Withdrawn 5Active not recruiting 3Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 179INDUSTRY 128NIH 31NETWORK 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 30Genitourinary 27Other hematologic neoplasm 26Lymphoid 25CNS 19Plasma cell 16Thoracic 15Gastrointestinal 14Head & Neck 7Sarcoma 6Myeloid 6Gynecologic 6Tumor-Agnostic 5Dermatologic 3Other neoplasm 2Endocrine 2Other solid neoplasm 1

Conditions

Melanoma 3

Interventions

encorafenib 1binimetinib 1Watchful Waiting 1Observation 1Nivolumab 1Ipilimumab 1Introns 1Interferon-alpha 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Dermatologic × Clear all
NCT00003641 2026-02-25

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
1,150 enrolled 6 charts
Dermatologic

Melanoma

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
271 enrolled
Dermatologic

Melanoma

NCT01942603 2023-11-28

Minitub

European Organisation for Research and Treatment of Cancer - EORTC

Active not recruiting
296 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡